Norda ASA Stock Price

OTCNO:NORD Community·NOK 436.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

NORD Share Price Performance

NOK 85.10

5.00 (6.24%)

NOK 85.10

5.00 (6.24%)

NOK 85.10

Thu, 12 Mar 26

Share Pricen/a

NORD Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks

2 Rewards

View Full Analysis

Norda ASA Key Details

Last Reported Earnings

Dec 31, 2024

Next Reporting Earnings

n/a

: 24.54
: 100.00%
: 33.87%
: 162.7%

View Full Analysis

About NORD

Founded: 2002
Employees: n/a
CEO: Hilde Leinaas
WebsiteView website: www.nordasa.no

Norda ASA, a biotechnology company, engages in the cancer diagnostic activities. Its involved in the research and development of Genefec, a diagnostic screening test for colorectal cancer. It also invests and trades in securities, real estates, and other assets. The company was formerly known as NorDiag ASA and changed its name to Norda ASA in July 2012. Norda ASA was incorporated in 2002 and is based in Oslo, Norway.